Literature DB >> 20679473

Validation of a radiographic scoring system for haemochromatosis arthropathy.

Tomás Dallos1, Enijad Sahinbegovic, Elmar Aigner, Roland Axmann, Maximilian Schöniger-Hekele, Thomas Karonitsch, Tanja Stamm, Martin Farkas, Thomas Karger, Alexander Cavallaro, Ulrich Stölzel, Gernot Keysser, Christian Datz, Georg Schett, Bernhard Manger, Jochen Zwerina.   

Abstract

BACKGROUND: Arthropathy is one of the earliest and most common manifestations of hereditary haemochromatosis with a significant impact on quality of life. Although its radiographic features are well known, there is no assessment tool for their evaluation.
OBJECTIVE: To develop and validate a novel scoring system for the evaluation of radiographic features of haemochromatosis arthropathy.
METHODS: A dichotomous scoring system assessing four radiographic features of haemochromatosis arthropathy and a 4-grade scale reflecting severity of radiographic change have been developed. Standard radiographs (hand, wrist, knee and ankle) of 170 subjects (116 male, 54 female) with genetically confirmed haemochromatosis and laboratory signs of iron overload were assessed by three readers and construct validity, feasibility and cross-sectional reliability (intrareader and inter-reader) were assessed.
RESULTS: Intrareader and inter-reader reliability as assessed by percentage pairwise agreement and Cohen's weighed κ were good to excellent for most features and locations evaluated. Radiographic scores correlated well with clinical parameters (bony swollen joint count, hand function and physician's global health assessment; Pearson's correlation, r²=0.18-0.62, p<0.0001). A complete set of radiographs took 3.4 ± 1.2 (mean ± SD) min to be assessed. An atlas of characteristic radiographic features was compiled.
CONCLUSION: A feasible and reliable radiological assessment tool for the evaluation of haemochromatosis arthropathy has been validated and an atlas of characteristic radiographic features provided.

Entities:  

Mesh:

Year:  2010        PMID: 20679473     DOI: 10.1136/ard.2009.122119

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  6 in total

1.  Hand X-ray examination in two planes is not required for radiographic assessment of hand osteoarthritis.

Authors:  Kevin Staats; Ilse-Gerlinde Sunk; Claudia Weidekamm; Andreas Kerschbaumer; Manuel Bécède; Gabriela Supp; Tanja Stamm; Reinhard Windhager; Josef S Smolen; Klaus Bobacz
Journal:  Ther Adv Musculoskelet Dis       Date:  2020-07-02       Impact factor: 5.346

Review 2.  HFE-related hemochromatosis: an update for the rheumatologist.

Authors:  Emma Husar-Memmer; Andreas Stadlmayr; Christian Datz; Jochen Zwerina
Journal:  Curr Rheumatol Rep       Date:  2014-01       Impact factor: 4.592

3.  Bone and joint complications in patients with hereditary hemochromatosis: a cross-sectional study of 93 patients.

Authors:  Chi-Duc Nguyen; Vincent Morel; Adeline Pierache; Georges Lion; Bernard Cortet; René-Marc Flipo; Valérie Canva-Delcambre; Julien Paccou
Journal:  Ther Adv Musculoskelet Dis       Date:  2020-07-16       Impact factor: 5.346

Review 4.  Diagnosis and Treatment of Genetic HFE-Hemochromatosis: The Danish Aspect.

Authors:  Nils Thorm Milman; Frank Vinholt Schioedt; Anders Ellekaer Junker; Karin Magnussen
Journal:  Gastroenterology Res       Date:  2019-10-04

5.  Iron Overload Induces Oxidative Stress, Cell Cycle Arrest and Apoptosis in Chondrocytes.

Authors:  Asima Karim; Khuloud Bajbouj; Jasmin Shafarin; Rizwan Qaisar; Andrew C Hall; Mawieh Hamad
Journal:  Front Cell Dev Biol       Date:  2022-02-18

6.  Ultrasound verified inflammation and structural damage in patients with hereditary haemochromatosis-related arthropathy.

Authors:  Christian Dejaco; Andreas Stadlmayr; Christina Duftner; Viktoria Trimmel; Rusmir Husic; Elisabeth Krones; Shahin Zandieh; Emma Husar-Memmer; Gernot Zollner; Josef Hermann; Judith Gretler; Angelika Lackner; Anja Ficjan; Christian Datz; Roland Axman; Jochen Zwerina
Journal:  Arthritis Res Ther       Date:  2017-10-24       Impact factor: 5.156

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.